| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/20/2001 | EP1107940A1 Vitamin d3 mimics |
| 06/20/2001 | EP1107812A1 Gelatinous body protection article having a therapeutic additive |
| 06/20/2001 | EP1107791A2 Hydrogel compositions for the controlled release administration of growth factors |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107780A2 Selective treatment of endothelial somatostatin receptors |
| 06/20/2001 | EP1107776A1 Dry extract of henna, method for producing said extract and use of the same |
| 06/20/2001 | EP1107775A1 Composition containing pyrrolizidine-alkaloid-free petasites |
| 06/20/2001 | EP1107768A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
| 06/20/2001 | EP1107766A2 Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis |
| 06/20/2001 | EP1107764A1 Use of solar radiation in the form of ointment, cream, lotion or solution for treating dermatosis |
| 06/20/2001 | EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 06/20/2001 | EP1107755A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107752A1 Pyrrolidine derivatives for vision and memory disorders |
| 06/20/2001 | EP1107738A1 Novel pharmaceutical salt form |
| 06/20/2001 | EP1107723A2 A carotenoid composition containing phytoene and phytofluene |
| 06/20/2001 | EP1107722A2 A method for the treatment of staphylococcal disease |
| 06/20/2001 | EP0767658A4 Anti-acne cosmetic compositions |
| 06/20/2001 | CN1300291A Modulators of protein tyrosine phosphatases |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/20/2001 | CN1300224A Protease inhibitors in absorbent articles |
| 06/20/2001 | CN1300223A Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 06/20/2001 | CN1300209A Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage |
| 06/20/2001 | CN1299654A Alopecia preventing and treating trichogen |
| 06/20/2001 | CN1299652A External-use lotion and its preparation |
| 06/20/2001 | CN1299649A External-use medicine for dermatosis and its preparation |
| 06/20/2001 | CN1299644A Face beautifying tissue milk |
| 06/20/2001 | CN1067259C Burns curing cream |
| 06/20/2001 | CN1067257C Drug for treating lupus erythematosus and preparation method |
| 06/20/2001 | CN1067253C Compounded sweet wormwood oil preparation for external use |
| 06/20/2001 | CN1067252C Cosmetics or pharmaceutical composition and use of antioxidation system in said composition |
| 06/20/2001 | CN1067246C Application of N-aceto-D-aminoglucose for preparing skin sanitary article preparation |
| 06/20/2001 | CN1067239C Multi-function health-care bath lotion and the method for mfg. same |
| 06/20/2001 | CN1067236C Hair conditioning and restoring tincture |
| 06/19/2001 | US6248864 Compounds and methods and modulating tissue permeability |
| 06/19/2001 | US6248785 IL-8 receptor antagonists |
| 06/19/2001 | US6248765 Imidazole derivatives as histamine receptor H3 (ANT) agonists |
| 06/19/2001 | US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 06/19/2001 | US6248749 Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acute damage induced by UV radiation |
| 06/19/2001 | US6248738 Isoquinolines as urokinase inhibitors |
| 06/19/2001 | US6248717 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 06/19/2001 | US6248713 Cell adhesion inhibitors |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248557 RatC |
| 06/19/2001 | US6248368 Administering magnesium salt |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248352 Compositions containing lipid compounds derived from sphingoid bases, their process of preparation |
| 06/19/2001 | US6248343 Mixture of triclosan and plant extract |
| 06/19/2001 | US6248341 Method of treating topical angiogenesis-related disorders |
| 06/19/2001 | US6248308 Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| 06/19/2001 | CA2191129C Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin |
| 06/19/2001 | CA2190973C Novel 4,6-diarylpyrimidine derivatives and salts thereof |
| 06/19/2001 | CA1341256C Combination of pyrimidine derivatives and non steroidal anti-inflammatory agents to induce and stimulate hair growth and reduce hair loss |
| 06/14/2001 | WO2001042457A2 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s prnas and their uses |
| 06/14/2001 | WO2001042449A2 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | WO2001042368A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042300A1 Process for producing functional silk fibroin and utilization of the same |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/14/2001 | WO2001042246A2 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 06/14/2001 | WO2001042241A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | WO2001042231A2 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001042216A2 Caspase inhibitors and uses thereof |
| 06/14/2001 | WO2001042189A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001041791A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 06/14/2001 | WO2001041778A1 Melanin synthesis inhibition compound and composition containing the same |
| 06/14/2001 | WO2001041776A2 Use of honey in medical dressings |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | WO2001041746A1 Anti itch patch |
| 06/14/2001 | WO2001041745A1 Anti pruritic patch |
| 06/14/2001 | WO2001041715A2 Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
| 06/14/2001 | WO2001041702A2 Zinc thiosalicylate, dermatological compositions containing same, in particular in the form of a self-adhesive device and method for preparing same |
| 06/14/2001 | WO2001041696A1 Electro-static stimulation of human body |
| 06/14/2001 | WO2001041651A2 Microdermabrasion device |
| 06/14/2001 | WO2001041573A1 Therapeutic antimicrobial compositions |
| 06/14/2001 | WO2001041567A1 Deep penetrating antimicrobial compositions |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001041534A2 Pseudomycin phosphate prodrugs |
| 06/14/2001 | WO2001027101A3 Anhydrous salt |
| 06/14/2001 | WO2001018040A3 Use of leptin in inhibition of endothelial cell proliferation |
| 06/14/2001 | WO2001016133A3 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 06/14/2001 | WO2001009113A3 Heterocyclic compounds inhibiting angiogenesis |
| 06/14/2001 | WO2001008632A3 Colloidal composition for esthetic correction |
| 06/14/2001 | WO2001003720A3 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 06/14/2001 | US20010003753 Methods for treatment of inflammatory diseases |
| 06/14/2001 | US20010003742 Antilipemic formulation |
| 06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
| 06/14/2001 | CA2396513A1 Pseudomycin phosphate prodrugs |
| 06/14/2001 | CA2394891A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393463A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392584A1 Substituted pyridazines having cytokine inhibitory activity |